Sign in

You're signed outSign in or to get full access.

Jennifer Taubert

Director at MCDONALDSMCDONALDS
Board

About Jennifer Taubert

Jennifer Taubert (age 61) is Executive Vice President and Worldwide Chairman, Innovative Medicine at Johnson & Johnson and has served on McDonald’s Board for 2 years. Her background includes senior leadership of a global pharmaceuticals division and membership on J&J’s executive committee, bringing regulatory/public policy and human capital management expertise to McDonald’s governance. She is currently an independent director at McDonald’s, not serving as a committee chair.

Past Roles

OrganizationRoleTenureCommittees/Impact
Johnson & JohnsonEVP & Worldwide Chairman, Innovative Medicine2018–PresentExecutive committee member; extensive regulatory/public policy and HCM experience
Johnson & JohnsonCompany Group Chairman, The Americas, Pharmaceuticals2015–2018Led pharmaceuticals across the Americas
Johnson & JohnsonCompany Group Chairman, North America, Pharmaceuticals2012–2015Led North America pharmaceuticals

External Roles

OrganizationRoleTenureCommittees/Impact
McDonald’s discloses no other current public company boards for Taubert

Board Governance

  • Committee memberships: Audit & Finance; Compensation. Not a committee chair. Audit & Finance met 8 times in 2024; Compensation met 4 times in 2024.
  • Independence: Board determined all non‑management directors, including Taubert, are independent under NYSE standards and McDonald’s policies.
  • Attendance: In 2024, the Board met 7 times; directors attended on average 96% of Board/committee meetings (each ≥75% attendance).
  • Executive sessions: Independent directors meet regularly; Chairman presides except on leadership/compensation matters, when the Lead Independent Director presides.
  • Outside board service policy: Directors may serve on no more than three other public company boards (in addition to MCD); prior notice/consent required, with resignation offer if notice not provided.

Fixed Compensation

ComponentProgram TermsTaubert 2024 Amount ($)
Annual cash retainer$120,000 cash retainer for directors120,000
Equity (stock equivalent units)Annual grant under Directors’ Plan; $205,000 value in 2024; credited at closing price; settled in cash after board service203,060 (grant date fair value)
Committee chair fees$30,000 (Audit & Finance Chair); $25,000 (Compensation, Governance, Corporate Responsibility Chairs)N/A (not a chair)
Lead Independent Director premiumAdditional $50,000 cash retainer (Miles White in 2024)N/A
Charitable matchUp to $10,000 matched annually10,000
Total (2024)333,060

Notes:

  • Directors may elect to defer retainers into stock equivalent units; units are payable in cash post‑service with lump sum or installments up to 15 years.
  • Directors’ equity awards are common stock equivalent units, not actual shares.

Performance Compensation

  • McDonald’s does not disclose performance‑contingent elements for director compensation; director equity is granted as stock equivalent units without performance metrics.

Other Directorships & Interlocks

CompanyRelationship to MCDNotes
NoneMcDonald’s lists zero other public company boards for Taubert; Board independence review considers any commercial relationships at employers and found none impairing independence.

Expertise & Qualifications

  • Senior executive experience in global, complex organizations; regulatory/public policy; human capital management; inclusion leadership; management/marketing/finance/business development/global operations (J&J).
  • Contribution to Board skill matrix includes brand management, customer‑centricity, finance/capital markets, global experience, HCM, IT/cyber, marketing, sustainability/corporate responsibility.

Equity Ownership

As of March 1, 2025Common Stock (shares)Stock Equivalents (units)Total
Jennifer Taubert0 2,565 2,565
  • Director ownership guidelines: Directors should own shares equal to 5x annual cash retainer within 5 years; McDonald’s states all directors are currently in compliance and prohibits hedging/pledging.
  • Observation: Taubert held no direct common shares as of March 1, 2025; holdings consist of cash‑settled stock equivalents under the Directors’ Plan.

Insider Filings

Filing DateFormKey Detail
2022-10-07Form 3Initial statement of beneficial ownership; “No securities are beneficially owned.”

Related Party Transactions and Conflicts

  • Policy: Board reviews/ratifies related person transactions; pre‑approves certain categories; directors must report conflicts; annual review performed.
  • Disclosure: Since Jan 1, 2023, no related person transactions >$120,000 in which a related person had a direct/indirect material interest.
  • Independence review: Board considered commercial relationships with companies where directors are employees; transactions were arm’s‑length and did not affect independence; all non‑management directors deemed independent.

Shareholder Engagement and Say‑on‑Pay Context

  • Engagement: Since last meeting, outreach to shareholders representing ~43% of outstanding shares; independent directors participate.
  • Executive pay governance: Robust pay‑for‑performance design for executives; not directly applicable to director pay.

Governance Assessment

  • Strengths: Independent status; service on key oversight committees (Audit & Finance; Compensation); Board reports strong overall attendance; robust related‑party and independence reviews; restrictions on outside boards and anti‑hedging/pledging policies.
  • Alignment considerations: As of March 1, 2025, Taubert held zero direct common shares and only cash‑settled stock equivalents, which may provide less direct “skin‑in‑the‑game” alignment versus owning shares; however, McDonald’s states all directors comply with ownership guidelines and director equity awards track McDonald’s stock performance.
  • Conflicts: Executive role at J&J could be a theoretical interlock if commercial ties existed; Board’s annual independence review concluded arm’s‑length relationships and maintained independence; no related‑party transactions reported.

RED FLAGS

  • Zero direct share ownership as of March 1, 2025 (ownership solely via cash‑settled stock equivalents). Monitoring for progress toward share ownership guideline compliance is prudent.